Malignant insulinoma: Recommendations for characterisation and treatment

被引:45
作者
Baudin, Eric [1 ]
Caron, Philippe [2 ]
Lombard-Bohas, Catherine [3 ]
Tabarin, Antoine [4 ]
Mitry, Emmanuel [5 ]
Reznick, Yves [6 ]
Taieb, David [7 ]
Pattou, Francois [8 ]
Goudet, Pierre [9 ]
Vezzosi, Delphine [2 ]
Scoazec, Jean-Yves [10 ]
Cadiot, Guillaume [11 ]
Borson-Chazot, Francoise [12 ]
Do Cao, Christine [13 ]
机构
[1] Inst Gustave Roussy, Serv Med Nucl & Oncol Endocrinienne, F-94800 Villejuif, France
[2] CHU Rangueil Larrey, Serv Endocrinol & Malad Metab, F-31400 Toulouse, France
[3] Hop Edouard Herriot, F-69003 Lyon, France
[4] Hop Haut Leveque, Serv Endocrinol, F-33604 Pessac, France
[5] Hop Ambroise Pare, Serv Hepatogastroenterol & Oncol Digest, F-92100 Boulogne, France
[6] CHU Cote Nacre, Unite Fonct Endocrinol & Malad Metab, F-14033 Caen, France
[7] CHU Timone, Serv Cent Biophys & Med Nucl, F-13385 Marseille, France
[8] Hop Claude Huriez, Serv Chirurg Endocrinienne, F-59037 Lille, France
[9] CHU Dijon, Serv Chirurg Gen & Endocrinienne, F-21079 Dijon, France
[10] Inst Gustave Roussy, Serv Biol & Pathol Med, F-94800 Villejuif, France
[11] Hop Robert Debre, Serv Hepatogastroenterol & Cancerol Digest, F-51090 Reims, France
[12] Hosp Civils Lyon, Ctr Med Nucl, F-69229 Lyon, France
[13] Hop Claude Huriez, Serv Endocrinol & Malad Metab, F-59037 Lille, France
关键词
NEUROENDOCRINE GASTROENTEROPANCREATIC TUMORS; RECEPTOR-MEDIATED RADIOTHERAPY; LONG-TERM SURVIVAL; PHASE-II TRIAL; SOMATOSTATIN ANALOG; LIVER METASTASES; PROGNOSTIC-FACTORS; ENDOCRINE TUMORS; SEVERE HYPOGLYCEMIA; MEDICAL-TREATMENT;
D O I
10.1016/j.ando.2013.07.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:523 / 533
页数:11
相关论文
共 129 条
[1]   PHENYTOIN IN METASTATIC INSULINOMA [J].
ADERKA, D ;
SHAKLAI, M ;
DORON, M ;
LARON, Z ;
PINHKAS, J ;
VRIES, AD .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1975, 234 (11) :1119-1119
[2]  
Albu A, 2008, J Med Life, V1, P210
[3]  
Almeida MQ, 2006, J ENDOCRINOL INVEST, V29, P679
[4]  
[Anonymous], 2011, THES NAT CANC DIG SO
[5]   Antitumour activity of somatostatin analogues in progressive metastatic neuroendocrine tumours [J].
Aparicio, T ;
Ducreux, M ;
Baudin, E ;
Sabourin, JC ;
De Baere, T ;
Mitry, E ;
Schlumberger, M ;
Rougier, P .
EUROPEAN JOURNAL OF CANCER, 2001, 37 (08) :1014-1019
[6]   Laparoscopic radiofrequency ablation of neuroendocrine liver metastases [J].
Berber, E ;
Flesher, N ;
Siperstein, AE .
WORLD JOURNAL OF SURGERY, 2002, 26 (08) :985-990
[7]   Efficacy of everolimus in patients with metastatic insulinoma and refractory hypoglycemia [J].
Bernard, Valerie ;
Lombard-Bohas, Catherine ;
Taquet, Marie-Caroline ;
Caroli-Bosc, Francois-Xavier ;
Ruszniewski, Philippe ;
Niccoli, Patricia ;
Guimbaud, Rosine ;
Chougnet, Cecile N. ;
Goichot, Bernard ;
Rohmer, Vincent ;
Borson-Chazot, Francoise ;
Baudin, Eric .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2013, 168 (05) :665-674
[8]   Role of hepatic arterial embolisation in the treatment for metastatic insulinoma - report of two cases and review of the literature [J].
Berwaerts, J ;
Verhelst, J ;
Hubens, H ;
Kunnen, J ;
Schrijvers, D ;
Joosens, E ;
Mahler, C ;
Van Gaal, L .
ACTA CLINICA BELGICA, 1997, 52 (05) :263-274
[9]   Successful Control of Intractable Hypoglycemia Using Rapamycin in an 86-Year-Old Man with a Pancreatic Insulin-Secreting Islet Cell Tumor and Metastases [J].
Bourcier, Matthew E. ;
Sherrod, Amanda ;
DiGuardo, Margaret ;
Vinik, Aaron I. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (09) :3157-3162
[10]  
Bushnell D, 2003, J NUCL MED, V44, P1556